Is hypomagnesaemia a coronary risk factor among Indians with coronary artery disease

Journal of Cardiovascular Disease Research

Volumn 3, Issue 4, 2012, Pages 280-286

  Mahalle, Namita ^a   Kulkarni, Mohan V ^b   Naik, Sadanand S ^a  

^a DEENANATH MANGESHKAR HOSPITAL   (India)

^b UNIVERSITY OF PUNE   (India)

Author keywords

Cardiovascular disease; dietary magnesium; dyslipidemia; serum magnesium

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; MAGNESIUM; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIETARY INTAKE; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; HYPOMAGNESEMIA; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 84870194657     PISSN: 09753583     EISSN: 09762833     Source Type: Journal    
DOI: 10.4103/0975-3583.102698     Document Type: Article

References (37)

1. Altura BM, Altura BT. Magnesium and cardiovascular biology: An important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res 1995;41:347-59.
2. Sasaki S, Oshima T, Matsuura H, Ozono R, Higashi Y, Sasaki N, et al. Abnormal magnesium status in patients with cardiovascular diseases. Clin Sci (Lond).2000;98:175-81.
3. Rosanoff A, Seelig MS. Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals. J Am Coll Nutr 2004;23:501S-5S.
4. Dyckner T, Westor PO. Potassium/magnesium depletion in patients with cardiovascular disease. Am J Med 1987;82:11-7.
5. Eichhorn EJ, Tandon PK, DiBianco R, Timmis GC, Fenster PE, Shannon J, et al. Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: The PROMISE Study. J Am Coll Cardiol 1993;21:634-40.
6. Vitale JJ, White PL, Nakamura M, Hegsted DM, Zancheck N, Hellerstein EE. Interrelationships between experimental hypercholesteremia, magnesium requirement, and experimental atherosclerosis. J Exp Med 1957;106:757-66.
7. Hellerstein EE, Vitale JJ, White PL, Hegested DM, Zamcheck N, Nakamura M. Influence of dietary magnesium on cardiac and renal lesions of young rats fed an atherogenic diet. J Exp Med 1957;106:767-76.
8. Nakamura M, Torii S, Hiramatsu M, Hiranjo J, Sumiyoshi A, Tanaka K. Dietary effect of magnesium on cholesterol-induced atherosclerosis of rabbits. J Atheroscler Res 1965;5:145-58.
9. Ito M, Toda T, Kummerow FA, Nishimori I. Effect of magnesium deficiency on ultrastructural changes in coronary arteries of swine. Acta Pathol Jpn 1986;36:225-34.
10. Jaya P, Kurup PA. Magnesium deficiency and metabolism of lipids in rats fed cholestorol-free and cholestorol-containing diet. Indian J Biochem Biophys 1987;24:92-5.
11. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 1995;48:927-40.
12. Manthey J, Stoeppler M, Morgenstern W, Nussel E,Opherk D, Weintraut A, et al. Magnesium and trace metals: Risk factors for coronary heart disease? Associations between blood levels and angiographic findings. Circulation 1981;64:722-9.
13. Rasmussen HS, Aurup P, Goldstein K, Mc Nair P, Mortensen BB, Larsen OG, et al. Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. A double-blind, placebo controlled study. Arch Intern Med 1989;149:1050-3.
14. Gopalan C, Rama Sastri BV, Balasubramanian SC. Nutritive value of Indian Foods 3rd ed. Revised and updated by Narasinga Rao BS, Deosthale YG, Pant KC. Hyderabad, India: Publisher-National Institute of Nutrition, Indian council of Medical Research; (1989) Reprint-2005. p. 1-156.
15. Stone MJ, Chowdrey PE, Miall P, Price CP. Validation of an enzymatic total magnesium determination based on activation of modified isocitrate dehydrogenase. Clin Chem 1996;42:1474-7.
16. Adamopoulos C, Pitt B, Sui X, Love TE, Zannad F, Ahmed A. Low serum magnesium and cardiovascular mortality in chronic heart failure: A propensity-matched study. Int J Cardiol 2009;136:270-7.
17. Gottlieb SS, Baruch L, Kukin ML, Bernstein JL,Fisher ML, Packer M. Prognostic importance of the serum magnesium in patients with congestive heart failure. J Am Coll Cardiol 1990;16:827-31.
18. Cappuccio FP, Markandu ND, Beynon GW, Shore AC, Sampson B, MacGregor GA. Lack of effect of oral magnesium on high blood pressure: A double blind study. Br Med J (Clin Res Ed) 1985;291:235-8.
19. Ferrara LA, Iannuzzi R, Castaldo A, Iannuzzi A, Dello Russo A, Mancini M. Long-term magnesium supplementation in essential hypertension. Cardiology 1992;81:25-33.
20. Joffres MR, Reed DM, Yano K. Relationship of magnesium intake and other dietary factors to blood pressure: The Honolulu heart study. Am J Clin Nutr 1987;45:469-75.
21. Whelton PK, Klag MJ. Magnesium and blood pressure: Review of the epidemiologic and clinical trial experience. Am J Cardiol 1989;63:26G-30G.
22. Van Leer EM, Seidell JC, Kromhout D. Dietary calcium, potassium, magnesium and blood pressure in the Netherlands. Int J Epidemiol 1995;24:1117-23.
23. Simons-Morton DG, Hunsberger SA, Van Horn L, Barton BA, Robson AM, McMahon RP, et al. Nutrient intake and blood pressure in the Dietary Intervention Study in Children. Hypertension 1997;29:930-6.
24. Peacock JM, Folsom AR, Arnett DK, Eckfeldt JH, Szklo M. Relationship of serum and Dietary Magnesium to Incident Hypertension: The Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 1999;9:159-65.
25. Schneider LE, Schedl H P. Effects of alloxan diabetes on magnesium metabolism in the rat. Proc Sot Exp Biol Med 1974;147:494-7.
26. Walti MK, Zimmermann MB, Spinas GA, Hurrell RF. Low plasma magnesium in type 2 diabetes. Swiss Med Wkly 2003;133:289-92.
27. Yajnik CS, Smith RF, Hockaday TD, Ward NI. Fasting plasma magnesium concentration and glucose disposal in diabetes. Br Med J (Clin Res Ed) 1984;288:1032-34.
28. Reffelmann T, Drr M, Ittermann T, Schwahn C, Vlzke H, Ruppert J, et al. Low serum magnesium concentrations predict increase in left ventricular mass over 5 years independently of common cardiovascular risk factors. Atherosclerosis 2010;213:563-9.
29. Gerrard JM, Stuart MJ, Rao GH, Staffes MW, Mauer SM, Brown DM, et al. Alternations in balance of prostaglandin and thromboxane synthesis in diabetic rats. J Lab Clin Med 1980;95:950-8.
30. Harrison HE, Reece AH, Johnson M. Decreased prostacyclin in experimental diabetes. Life Sci 1978; 23:351-5.
31. Nasri H, Baradaran HR. Lipids in association with serum magnesium in diabetes mellitus patients. Bratisl Lek Listy 2008;109:302-6.
32. Guerrero-Romero F, Rodrguez-Morn M. Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values. J Diabetes Complications 2000;14:272-6.
33. Corica F, Corsonello A, Ientile R, Cacinotta D, Di Benedetto A, Perticone F, et al. Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J Am Coll Nutr 2006;25:210-5.
34. Guerrero-Romero F, Rodrguez-Morn M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol 2002;39:209-13.
35. Randell EW, Mathews M, Gadag V, Zhang H, Sun G. Relationship between serum magnesium values, lipids and anthropometric risk factors. Atherosclerosis 2008;196:413-9.
36. Haenni A, Ohrvall M, Lithell H. Atherogenic lipid fractions are related to ionized magnesium status. Am J Clin Nutr 1998;67:202-7.
37. Abbott RD, Ando F, Masaki KH, Tung KH, Rodriquez BL, Petrovitch H, et al. Dietary magnesium intake and the future risk of coronary heart disease (the honolulu heart program). Am J Cardiol 2003;92:665-9.